PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
3,056,434
Share change
+2,500
Total reported value
$64,872,488
Price per share
$21.36
Number of holders
50
Value change
+$85,284
Number of buys
15
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q1 2018

As of 31 Mar 2018, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,056,434 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Moors & Cabot, Inc., Tieton Capital Management, LLC, CRAWFORD INVESTMENT COUNSEL INC, VANGUARD GROUP INC, Uniplan Investment Counsel, Inc., DIMENSIONAL FUND ADVISORS LP, BLAIR WILLIAM & CO/IL, North Star Investment Management Corp., and RBF Capital, LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.